EDAP TMS SA (EDAP) - Total Liabilities

Latest as of March 2026: $61.96 Million USD

Based on the latest financial reports, EDAP TMS SA (EDAP) has total liabilities worth $61.96 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

EDAP TMS SA - Total Liabilities Trend (1997–2025)

This chart illustrates how EDAP TMS SA's total liabilities have evolved over time, based on quarterly financial data. See working capital position of EDAP TMS SA to evaluate short-term liquidity relative to the company's equity base.

EDAP TMS SA Competitors by Total Liabilities

The table below lists competitors of EDAP TMS SA ranked by their total liabilities.

Company Country Total Liabilities
Unic Technology
TWO:5452
Taiwan NT$1.64 Billion
Meridian Holdings Inc
NASDAQ:MRDN
USA $61.44 Million
Lippo Cikarang Tbk
JK:LPCK
Indonesia Rp4.34 Trillion
Condor Energies Inc.
TO:CDR
Canada CA$86.14 Million
Cartesian Growth Corporation II Class A Ordinary Shares
NASDAQ:RENE
USA $20.70 Million
Nnit AS
CO:NNIT
Denmark Dkr731.00 Million
Fu Yu Property Co Ltd
TWO:4907
Taiwan NT$5.81 Billion
Cheil Electric Wiring Devices Co. Ltd.
KQ:199820
Korea ₩77.55 Billion

Liability Composition Analysis (1997–2025)

This chart breaks down EDAP TMS SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see EDAP TMS SA (EDAP) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.34 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 6.13 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.86 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how EDAP TMS SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for EDAP TMS SA (1997–2025)

The table below shows the annual total liabilities of EDAP TMS SA from 1997 to 2025.

Year Total Liabilities Change
2025-12-31 $59.58 Million +31.92%
2024-12-31 $45.17 Million +30.45%
2023-12-31 $34.62 Million +17.40%
2022-12-31 $29.49 Million +8.55%
2021-12-31 $27.17 Million -6.13%
2020-12-31 $28.95 Million +12.58%
2019-12-31 $25.71 Million +8.13%
2018-12-31 $23.78 Million +9.37%
2017-12-31 $21.74 Million -1.81%
2016-12-31 $22.14 Million -8.33%
2015-12-31 $24.15 Million +41.96%
2014-12-31 $17.01 Million -3.28%
2013-12-31 $17.59 Million -21.06%
2012-12-31 $22.28 Million -6.52%
2011-12-31 $23.84 Million -11.84%
2010-12-31 $27.04 Million -2.74%
2009-12-31 $27.80 Million +4.23%
2008-12-31 $26.67 Million -12.70%
2007-12-31 $30.55 Million +131.93%
2006-12-31 $13.17 Million +15.40%
2005-12-31 $11.42 Million +14.96%
2004-12-31 $9.93 Million -23.18%
2003-12-31 $12.93 Million +13.16%
2002-12-31 $11.42 Million -19.73%
2001-12-31 $14.23 Million -9.08%
2000-12-31 $15.65 Million -25.44%
1999-12-31 $20.99 Million +2.58%
1998-12-31 $20.46 Million +19.74%
1997-12-31 $17.09 Million --

About EDAP TMS SA

NASDAQ:EDAP USA Medical Distribution
Market Cap
$178.79 Million
Market Cap Rank
#17627 Global
#4096 in USA
Share Price
$4.77
Change (1 day)
+1.49%
52-Week Range
$1.25 - $4.91
All Time High
$12.49
About

EDAP TMS S.A., a medical technology company, engages in the development, manufacturing, marketing, and sale of non-invasive therapeutic ultrasound and energy-based medical devices in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution segments. The HIFU segment de… Read more